Yüklüyor......
The use of erythropoietin in renal failure.
The treatment of renal anaemia by recombinant human erythropoietin (EPO) is now well established. Several studies have examined the pharmacokinetics and efficacy of the drug given intravenously, intraperitoneally and subcutaneously and there is increasing evidence that the subcutaneous route has sev...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Group
1991
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2398938/ https://ncbi.nlm.nih.gov/pubmed/2057440 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|